QC Lab Analyst II (contract) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sanofi · 4 days ago

QC Lab Analyst II (contract)

Sanofi is seeking a Laboratory Analyst II for a 12 month contract to support Quality Control Physico Chemistry activities. The role involves performing routine physico-chemical testing, executing assays, and maintaining data integrity while supporting general lab operations.

Health CareLife SciencePharmaceuticalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Perform routine physico-chemical testing of samples in accordance with QC procedures
Execute assays including: pH testing, Moisture analysis, Wet chemistry / UV-Vis, HPLC
Accurately document and report test results while maintaining data integrity
Support general lab operations and equipment upkeep

Qualification

HPLCWet chemistry / UV-VisMoisture testingSample testingPreparationGMP documentation practicesLIMS experienceAttention to detail

Required

Bachelor's degree in Chemistry or a related scientific field
3–5 years of experience in a QC or analytical laboratory environment
Hands-on experience with: Sample testing and preparation, HPLC, Wet chemistry / UV-Vis, Moisture testing
Strong attention to detail and adherence to GMP documentation practices

Preferred

Prior experience using a LIMS or similar electronic documentation system
Exposure to osmolality testing (training will be provided; no prior experience required)

Benefits

Flu vaccination required.

Company

Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.

H1B Sponsorship

Sanofi has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)

Funding

Current Stage
Public Company
Total Funding
$6.97B
Key Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B

Leadership Team

leader-logo
Paul Hudson
Chief Executive Officer
linkedin
leader-logo
Francois-Xavier Roger
Chief Financial Officer
linkedin
Company data provided by crunchbase